[1]
Pivtorak, K.V. 2017. Features of nonalcoholic fatty liver disease pharmacotherapy in patients with overweight and obesity. Zaporozhye Medical Journal. 4 (Jul. 2017). DOI:https://doi.org/10.14739/2310-1210.2017.4.105301.